OptimizeRx (OPRX)
(Delayed Data from NSDQ)
$12.15 USD
-0.51 (-4.03%)
Updated May 29, 2024 04:00 PM ET
After-Market: $12.17 +0.02 (0.16%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
Brokerage Reports
0 items in cart
OptimizeRx Corp. [OPRX]
Reports for Purchase
Showing records 21 - 40 ( 124 total )
Company: OptimizeRx Corp.
Industry: Computer - Software
Downside Results Widely Miss; Cutting Price Target to $31.00
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Software: Upcoming London Conference Offers Timely Access
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
High Beta Macro Attack Mistakenly Targets Defensible Fast-Growers
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Guidance Reiteration Leaves Pullback an Opportunity; PT to $66.00
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Preliminary 4Q21 Results Good & First Ever Guidance Strong for 2022
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Strong Growth Sustained & Pipeline Implies is Sustainable; PT to $112.00
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Enterprise Wins Loading the Spring for Next Level Growth
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
RFP Pipeline Portends Rapid Growth Again in 2021; PT Increased to $85.00
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Impressive 4Q20 Upside Announced; Reiterate Recently Increased $70 PT
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R